ALS--dying forward, backward or outward?
作者信息
Baker Mark R
机构信息
Institute of Neuroscience, Henry Wellcome Building, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.
出版信息
Nat Rev Neurol. 2014 Nov;10(11):660. doi: 10.1038/nrneurol.2013.221-c1. Epub 2014 Sep 23.
Abstract
摘要
相似文献
1
ALS--dying forward, backward or outward?
Nat Rev Neurol. 2014 Nov;10(11):660. doi: 10.1038/nrneurol.2013.221-c1. Epub 2014 Sep 23.
2
Amyotrophic lateral sclerosis--a model of corticofugal axonal spread.
Nat Rev Neurol. 2013 Dec;9(12):708-14. doi: 10.1038/nrneurol.2013.221. Epub 2013 Nov 12.
3
Mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex.
J Neurochem. 2021 May;157(4):1300-1315. doi: 10.1111/jnc.15214. Epub 2020 Nov 9.
4
Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels.
Hum Mol Genet. 2017 Dec 1;26(23):4668-4679. doi: 10.1093/hmg/ddx348.
5
TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis.
Transl Neurodegener. 2022 Dec 27;11(1):56. doi: 10.1186/s40035-022-00331-z.
6
Mitofusin 2 Regulates Axonal Transport of Calpastatin to Prevent Neuromuscular Synaptic Elimination in Skeletal Muscles.
Cell Metab. 2018 Sep 4;28(3):400-414.e8. doi: 10.1016/j.cmet.2018.06.011. Epub 2018 Jul 12.
7
Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43 transgenic mouse model of amyotrophic lateral sclerosis.
FASEB J. 2018 May;32(5):2676-2689. doi: 10.1096/fj.201700835R. Epub 2018 Jan 2.
8
Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes.
Acta Neuropathol Commun. 2016 Jun 23;4(1):61. doi: 10.1186/s40478-016-0335-2.
9
Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria.
Hum Mol Genet. 2012 May 1;21(9):1979-88. doi: 10.1093/hmg/dds011. Epub 2012 Jan 17.
10
C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
Autophagy. 2021 Nov;17(11):3306-3322. doi: 10.1080/15548627.2021.1872189. Epub 2021 Feb 26.
引用本文的文献
1
Treating amyotrophic lateral sclerosis with allogeneic Schwann cell-derived exosomal vesicles: a case report.
Neural Regen Res. 2025 Apr 1;20(4):1207-1216. doi: 10.4103/NRR.NRR-D-23-01815. Epub 2024 Apr 3.
2
Neuronal Circuit Dysfunction in Amyotrophic Lateral Sclerosis.
Cells. 2024 May 7;13(10):792. doi: 10.3390/cells13100792.
3
History of ALS and the competing theories on pathogenesis: IFCN handbook chapter.
Clin Neurophysiol Pract. 2023 Dec 12;9:1-12. doi: 10.1016/j.cnp.2023.11.004. eCollection 2024.
4
Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms.
Mol Neurodegener. 2023 Oct 19;18(1):75. doi: 10.1186/s13024-023-00665-w.
5
Validation of Functional Connectivity of Engineered Neuromuscular Junction With Recombinant Monosynaptic Pseudotyped ΔG-Rabies Virus Tracing.
Front Integr Neurosci. 2022 May 20;16:855071. doi: 10.3389/fnint.2022.855071. eCollection 2022.
6
Caudal-Rostral Progression of Alpha Motoneuron Degeneration in the SOD1 Mouse Model of Amyotrophic Lateral Sclerosis.
Antioxidants (Basel). 2022 May 17;11(5):983. doi: 10.3390/antiox11050983.
7
Upper motor neurons are a target for gene therapy and UCHL1 is necessary and sufficient to improve cellular integrity of diseased upper motor neurons.
Gene Ther. 2022 Apr;29(3-4):178-192. doi: 10.1038/s41434-021-00303-4. Epub 2021 Dec 2.
8
How Are Adenosine and Adenosine A Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?
Biomedicines. 2021 Aug 17;9(8):1027. doi: 10.3390/biomedicines9081027.
9
Metabolic changes in an animal model of amyotrophic lateral sclerosis evaluated by [F]-FDG positron emission tomography.
Transl Neurodegener. 2021 Jun 23;10(1):21. doi: 10.1186/s40035-021-00246-1.
10
The Cortical "Upper Motoneuron" in Health and Disease.
Brain Sci. 2021 May 12;11(5):619. doi: 10.3390/brainsci11050619.
本文引用的文献
1
Amyotrophic lateral sclerosis--a model of corticofugal axonal spread.
Nat Rev Neurol. 2013 Dec;9(12):708-14. doi: 10.1038/nrneurol.2013.221. Epub 2013 Nov 12.
2
Characterization of prion-like conformational changes of the neuronal isoform of Aplysia CPEB.
Nat Struct Mol Biol. 2013 Apr;20(4):495-501. doi: 10.1038/nsmb.2503. Epub 2013 Feb 24.
3
Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease.
Brain. 2012 Sep;135(Pt 9):2849-64. doi: 10.1093/brain/aws150. Epub 2012 Jun 22.
4
Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?
J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):739-45. doi: 10.1136/jnnp-2011-301826. Epub 2012 Apr 27.
5
Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43.
Brain. 2012 Mar;135(Pt 3):833-46. doi: 10.1093/brain/awr348. Epub 2012 Jan 17.
6
Morphological and functional abnormalities in mitochondria associated with synaptic degeneration in prion disease.
Am J Pathol. 2010 Sep;177(3):1411-21. doi: 10.2353/ajpath.2010.091037. Epub 2010 Jul 22.
7
Genetics of motor neuron disorders: new insights into pathogenic mechanisms.
Nat Rev Genet. 2009 Nov;10(11):769-82. doi: 10.1038/nrg2680. Epub 2009 Oct 13.
8
Descending pathways in motor control.
Annu Rev Neurosci. 2008;31:195-218. doi: 10.1146/annurev.neuro.31.060407.125547.
9
Motor neuron disease in a patient with a mitochondrial tRNAIle mutation.
Ann Neurol. 2006 Mar;59(3):570-4. doi: 10.1002/ana.20758.
10
Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS.
Neurology. 2003 Apr 22;60(8):1252-8. doi: 10.1212/01.wnl.0000058901.75728.4e.
Zotero 插件